DOMNUVA Trademark

Trademark Overview


On Monday, February 17, 2025, a trademark application was filed for DOMNUVA with the United States Patent and Trademark Office. The USPTO has given the DOMNUVA trademark a serial number of 79421642. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Friday, May 2, 2025. This trademark is owned by Gilead Sciences Ireland UC. The DOMNUVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations.
domnuva

General Information


Serial Number79421642
Word MarkDOMNUVA
Filing DateMonday, February 17, 2025
Status640 - NON-FINAL ACTION COUNTED - NOT MAILED
Status DateFriday, May 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 17, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type79 - NOT AVAILABLE
AddressIE

Trademark Events


Event DateEvent Description
Thursday, April 17, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, April 28, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 2, 2025ASSIGNED TO EXAMINER
Monday, April 28, 2025APPLICATION FILING RECEIPT MAILED
Friday, May 2, 2025NON-FINAL ACTION WRITTEN
Saturday, May 3, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW